Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.31576 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.26654 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.22465 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.21858 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.2045 | 52 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.33459 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.28532 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.24169 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.26938 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.22018 | 51 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.25162 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.29126 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.24186 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.25231 | 52 |